Received tentative approval from the FDA for YUTREPIAâ„¢ (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung ...
Some results have been hidden because they may be inaccessible to you